Premium
Nucleoside diphosphate‐linked moiety X‐type motif 15 C415T variant as a predictor for thiopurine‐induced toxicity in Indian patients
Author(s) -
Shah Swarup A V,
Paradkar Minal,
Desai Devendra,
Ashavaid Tester F
Publication year - 2017
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.13494
Subject(s) - thiopurine methyltransferase , leukopenia , genotyping , medicine , itpa , toxicity , allele , genotype , gastroenterology , azathioprine , genetics , gene , biology , disease , ribavirin
Background and Aim Interindividual variation seen in the thiopurine metabolism is attributed to the genetic variant in thiopurine methyltransferase ( TPMT ) gene leading to myelosuppression. In Asians, the thiopurine‐induced toxicity is not completely explained by TPMT variants. Literature indicates that a newer genetic variant in nucleoside diphosphate‐linked moiety X‐type motif 15 ( NUDT15 ) gene is associated with thiopurine intolerance. We aimed to determine the risk allele frequency of NUDT15 genetic variant and its association with thiopurine‐induced toxicity in Indian patients. Methods In this pilot study, 69 patients on thiopurine therapy were analyzed. The frequencies of thiopurine‐induced leukopenia were recorded. NUDT15 (C415T) and TPMT (*2, *3A, *3B, and *3C) genotyping was performed using amplification refractory mutation system–polymerase chain reaction and restriction fragment length polymorphism technique. Results were validated by DNA sequencing. Results The NUDT15 CC, CT, and TT genotypes were found to be 86.9%, 11.5%, and 1.5%, respectively, whereas TPMT genetic variants were absent. Of 60 patients without NUDT15 variant, none developed leukopenia, whereas of nine patients with NUDT15 variant, six developed leukopenia ( P ‐value < 0.0001). The mean thiopurine dose of 1.01 and 0.73 mg/kg/day for patients with wild and mutant NUDT15 alleles, respectively, was statistically significant ( P < 0.01). The sensitivity and specificity for NUDT15 variant were 100% and 95.2%, respectively. Conclusions The NUDT15 risk allele frequency was 7.2%. There are 6/69 (8.7%) patients who developed leukopenia and harbored NUDT15 variant, thus showing a strong association for thiopurine‐induced toxicity. Hence, NUDT15 genotyping may be considered before thiopurine therapy in Indian patients.